↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$3.9MSold on the market
1Companies
Sep 24, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 202616:29 | Sep 22, 2026 | TXG10x Genomics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $81.22 | −25,000 | 1,050,249 | -2% | −$2.0M | ||
| Sep 3, 202617:19 | Sep 1, 2026 | TXG10x Genomics, Inc. | Chief Executive Officer, Director | G · Gift | — | −100 | 1,075,249 | -0% | — | ||
| Aug 28, 202619:22 | Aug 26, 2026 | TXG10x Genomics, Inc. | Chief Executive Officer, Director | S · Sell10b5-1 | $63.69 | −10,486 | 1,075,349 | -1% | −$668K | ||
| Aug 26, 202616:46 | Aug 24, 2026 | TXG10x Genomics, Inc. | Chief Executive Officer, Director | S · Sell | $63.02 | −18,545 | 1,085,835 | -2% | −$1.2M | ||
| Aug 24, 202616:16 | Aug 20, 2026 | TXG10x Genomics, Inc. | Chief Executive Officer, Director | G · Gift | — | −4,000 | 1,104,380 | -0% | — |